MetLife Investment Advisors »

Avita Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $187k 14k 13.72
2023-09-30 $199k 14k 14.61
2023-06-30 $232k 14k 17.01
2021-12-31 $125k 11k 11.98
2021-09-30 $185k 11k 17.72
2021-06-30 $215k 11k 20.52